# Panbela Therapeutics, Inc. (PBLA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PBLA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -22.53M | $ -13.13M | $ 6.39M | $ -18.17M |
| 2023 | $ 0 | $ -27.30M | $ -27.30M | $ 5.19M | $ -4.71M |
| 2022 | $ -1.83M | $ -39.02M | $ -17.06M | $ 6.84M | $ -8.05M |
| 2021 | $ -1.44M | $ -12.03M | $ -7.97M | $ 0 | $ 10.21M |
| 2020 | $ 1.65M | $ -6.07M | $ -4.91M | $ 0 | $ 8.45M |
| 2019 | $ -3.09M | $ -8.01M | $ -3.54M | $ 116.0K | $ 1.39M |
| 2018 | $ -3.67M | $ -7.92M | $ -3.15M | $ 350.0K | $ 268.0K |
| 2017 | $ -6.25M | $ -13.96M | $ -4.58M | $ 1.83M | $ -3.69M |
| 2016 | $ -539.3K | $ -7.04M | $ -3.30M | $ 3.28M | $ -4.64M |
| 2015 | $ -425.4K | $ -2.20M | $ -5.47M | $ 3.33M | $ -2.68M |
| 2014 | $ 1.92M | $ -151.3K | $ -25.8K | $ 576.8K | $ -211.0K |
| 2013 | $ 1.38M | $ -293.3K | $ -57.6K | $ 581.7K | $ -137.9K |
| 2012 | $ 1.78M | $ 357.2K | $ -9.6K | $ 586.3K | $ -40.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.35 |
| Liabilities / Eq | -1.28 |
| Current Ratio | 0.26 |

## Other views

- [Metrics](https://sponda.capital/en/PBLA.md)
- [Charts](https://sponda.capital/en/PBLA/charts.md)
- [Compare](https://sponda.capital/en/PBLA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.